Vireo Growth (VREOF) Return on Assets Growth (3y) (2024 - 2026)

Vireo Growth (VREOF) Return on Assets Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.87 Bn	42.91 Bn	-
2	Teva Pharmaceutical Industries	43.21 Bn	39.55 Bn	2.15 Bn
3	Zoetis	31.48 Bn	29.80 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn
5	United Therapeutics	22.19 Bn	19.53 Bn	683.80 Mn
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn
7	Neurocrine Biosciences	15.49 Bn	15.10 Bn	935.80 Mn
8	Elanco Animal Health	11.70 Bn	11.17 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-
10	Vireo Growth	489.19 Mn	346.89 Mn	95.30 Mn

Download Data